Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • Stakk Secures T-Mobile Contract to Power Super App Expansion
    Stakk Secures T-Mobile Contract to Power Super App Expansion
    • News

  • Medibank Backs Emyria with Landmark Depression Care Deal
    Medibank Backs Emyria with Landmark Depression Care Deal
    • News

  • NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    NoviqTech Launches Quantum Intelligence Products, Opening Path to Enterprise-Grade Quantum AI
    • News

  • BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    BRE Wins Final Permit to Advance Rare Earth Pilot Plant in Brazil
    • News

  • Harris Technology eyes profitability as refurbished tech sales surge
    Harris Technology eyes profitability as refurbished tech sales surge
    • News

  • QIC Fund Backs Ark Mines with $4.5m to Accelerate Sandy Mitchell Development
    • News

  • Swift Secures $2.4m Chevron Contract to Extend Entertainment and Support Services
    Swift Secures $2.4m Chevron Contract to Extend Entertainment and Support Services
    • News

  • FBR’s tech could help reduce housing construction-related cost pressures
    FBR’s tech could help reduce housing construction-related cost pressures
    • News

  • Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US
    • News

  • June 2025 quarter CPI no roadblock to August RBA rate cut
    June 2025 quarter CPI no roadblock to August RBA rate cut
    • News

PainChek steps into the Japanese market, taps into the region’s massive ageing population

  • In News
  • September 26, 2022
  • Alinda Gupta
PainChek steps into the Japanese market, taps into the region’s massive ageing population

Japanese caretakers will soon be able to look at non-verbal babies’ and senior citizens’ faces and break down facial expressions to understand if they are in pain. Digital pain assessment app PainChek Limited (ASX: PCK) has announced that it is expanding its activities to Japan following its acceptance into the Japan External Trade Organisation (JETRO) Business Connect program for 2022. 

JETRO is Japan’s core governmental organisation, which promotes inward foreign business. The organisation will help the Australian-based company enter the Japanese market. PainChek will be provided with Japan’s market data and a series of online business matching events connecting PainChek with local partners throughout Japan and guidance in relation to the Japanese regulatory clearance processes. 

To enable the expansion, PainChek had to undergo JETRO’s screening process before qualifying to enter the market. It had to partake in a series of face-to-face meetings in London and achieve a set criteria. 

PainChek’s Chief Executive Officer, Philip Daffas, commented, “A priority for JETRO was identifying companies for the program that had developed new digital healthcare technologies, with image diagnosis a specific focus point.”

“This made PainChek an outstanding candidate for JETRO and both parties are excited by the potential for collaboration with organisations in Japan and the positive outcomes it could lead to.”

About 30% of Japan’s population is 65 or older, the highest among all countries globally. This provides PainChek with a great opportunity to tap into the market. Estimates suggest that 6.7 million  Japanese citizens require care, and nearly a million are currently in aged care facilities. Thankfully for PainChek, it already boasts considerable experience in the area. The app is currently used in over 1,500 aged care facilities around the world. 

PainChek intends on using this opportunity to tap into others as well. It aims to combine its offering with Japan’s high tech, devices and artificial intelligence capabilities. The Telethon Kids Institute in conjunction with PainChek has been provided Government funding of nearly $400k to develop an app for children with disabilities to detect pain in kids who can’t tell you when it hurts.

Moreover, PainChek has been focusing on expanding to other regions as well. In July this year, it received funding from the Gwent Regional Partnership Board in Wales to support a 12-month pilot in care environments across Gwent, Wales.

As for its Japan expansion, starting this month, the Company’s representatives will start virtually meeting with other companies, research groups and government officials across the region to assist in business development opportunities in the country, backed by PR initiatives to increase awareness of the PainChek business and technology. 

Daffas concluded, “This new initiative combined with our recent contact with FDA means PainChek can now plan effectively for market entry into the USA and Japan – two of the world’s largest medical device and aged care markets.”

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  •  
  •  
  •  
  •  
  • gwent regional partnership board
  • jetro
  • PainChek
  • philip daffas
  • Tech
  • News

Leave a Comment

You must be logged in to post a comment.

  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Alinda Gupta
Alinda is a Business Reporter for The Sentiment
Latest posts by Alinda Gupta (see all)
  • Ovanti’s iSentric signs contracts worth $14.4m with Malaysian commercial bank - June 27, 2024
  • Baby Bunting fights back from retail downturn with 5-year strategy, includes Gen-Z focus and self-funded growth - June 27, 2024
  • CLEO meets with US FDA to develop strategy for ovarian cancer test launch - June 26, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.